Pfizer Talks Tough: Launches And Licensing Will Ride Out Patent Expirations
This article was originally published in The Pink Sheet Daily
Executive Summary
"The environment is tough" but "Pfizer is tougher," CEO McKinnell declares. Pfizer will be able to weather $14 bil. in patent losses in the coming years thanks to strong late-stage pipeline and "under-estimated" position as partner of choice.